Filtros de búsqueda

Lista de obras de

20-25% lower concentrations of total and free prostate-specific antigen (PSA) after calibration of PSA assays to the WHO reference materials--analysis of 1098 patients in four centers

artículo científico publicado en 2009

A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

artículo científico publicado en 2019

A 3-plex methylation assay combined with the FGFR3 mutation assay sensitively detects recurrent bladder cancer in voided urine

artículo científico publicado en 2013

A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam

artículo científico publicado en 2012

A Decade of Active Surveillance in the PRIAS Study: An Update and Evaluation of the Criteria Used to Recommend a Switch to Active Treatment

artículo científico publicado en 2016

A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range

artículo científico publicado el 17 de marzo de 2011

A Multicentre Evaluation of the Role of the Prostate Health Index (PHI) in Regions with Differing Prevalence of Prostate Cancer: Adjustment of PHI Reference Ranges is Needed for European and Asian Settings

article

A longitudinal study on the impact of active surveillance for prostate cancer on anxiety and distress levels

artículo científico publicado en 2014

A methylation assay for the detection of non-muscle-invasive bladder cancer (NMIBC) recurrences in voided urine.

artículo científico publicado en 2011

A new and highly prognostic system to discern T1 bladder cancer substage.

artículo científico publicado en 2011

A prostate cancer vaccine comprising whole cells secreting IL-7, effective against subcutaneous challenge, requires local GM-CSF for intra-prostatic efficacy

artículo científico publicado en 2008

A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer.

artículo científico publicado en 2009

A small chimeric promoter for high prostate-specific transgene expression from adenoviral vectors

artículo científico publicado en 2007

A standardised study to compare prostate cancer targeting efficacy of five radiolabelled bombesin analogues

artículo científico publicado en 2010

Absolute Effect of Prostate Cancer Screening: Balance of Benefits and Harms by Center within the European Randomized Study of Prostate Cancer Screening.

artículo científico publicado en 2015

Abstract 1932: Cationic amphiphilic drugs as a potential new treatment option for patients with high risk non-muscle invasive bladder cancer

scholarly article

Abstract 4023: Genome-wide analysis of CpG island methylation identified OTX1, OSR1 and ONECUT2 as biomarkers for recurrent bladder cancer detection in voided urine

Active surveillance for low-risk prostate cancer

artículo científico publicado en 2013

Active surveillance for low-risk prostate cancer worldwide: the PRIAS study.

artículo científico publicado en 2012

Active surveillance for low-risk prostate cancer: developments to date

artículo científico publicado en 2014

Active surveillance for prostate cancer: a narrative review of clinical guidelines

artículo científico publicado en 2016

Active surveillance: oncologic outcome

artículo científico

Active surveillance: protocol makes perfect

artículo científico publicado en 2014

Additional benefit of using a risk-based selection for prostate biopsy: an analysis of biopsy complications in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer

artículo científico publicado en 2017

Adenovirus-derived vectors for prostate cancer gene therapy

scientific article published on July 2010

Adherence to Active Surveillance Protocols for Low-risk Prostate Cancer: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance Initiative

scientific article published on 26 September 2019

Algorithms based on prostate-specific antigen (PSA), free PSA, digital rectal examination and prostate volume reduce false-positive PSA results in prostate cancer screening

artículo científico publicado en 2004

An inventory of shedding data from clinical gene therapy trials

artículo científico publicado en 2007

Analysis of the video motion tracking system "Kinovea" to assess surgical movements during robot-assisted radical prostatectomy

artículo científico publicado en 2020

Anxiety and distress during active surveillance for early prostate cancer.

artículo científico publicado en 2009

Bladder cancer biomarkers and their role in surveillance and screening

artículo científico publicado en 2009

Bladder carcinogenesis, in search of clues and genes.

artículo científico publicado en 2006

Body mass index as a prognostic marker for biochemical recurrence in Dutch men treated with radical prostatectomy.

artículo científico publicado en 2009

C/D-box snoRNA-derived RNA production is associated with malignant transformation and metastatic progression in prostate cancer

artículo científico publicado en 2015

Can active surveillance really reduce the harms of overdiagnosing prostate cancer? A reflection of real life clinical practice in the PRIAS study.

artículo científico publicado en 2018

Can dutasteride delay or prevent the progression of prostate cancer in patients with biochemical failure after radical therapy? Rationale and design of the Avodart after Radical Therapy for Prostate Cancer Study.

artículo científico publicado en 2009

Can non-malignant biopsy features identify men at increased risk of biopsy-detectable prostate cancer at re-screening after 4 years?

artículo científico publicado en 2007

Cationic amphiphilic drugs as potential anti-cancer therapy for bladder cancer

artículo científico publicado en 2020

Characteristics and outcome of prostate cancer patients with overall biopsy Gleason score 3 + 4 = 7 and highest Gleason score 3 + 4 = 7 or > 3 + 4 = 7.

artículo científico publicado en 2017

Characteristics of Prostate Cancer Found at Fifth Screening in the European Randomized Study of Screening for Prostate Cancer Rotterdam: Can We Selectively Detect High-grade Prostate Cancer with Upfront Multivariable Risk Stratification and Magnetic

artículo científico publicado en 2017

Clinical adenoviral gene therapy for prostate cancer

scientific article published on July 2010

Clinical outcome comparison of Grade Group 1 and Grade Group 2 prostate cancer with and without cribriform architecture at the time of radical prostatectomy

scientific article published on 16 January 2020

Clinically significant prostate cancer detection and segmentation in low-risk patients using a convolutional neural network on multi-parametric MRI

artículo científico publicado en 2020

Clinicopathological characteristics of glomeruloid architecture in prostate cancer

artículo científico publicado en 2020

Comparison of Tumor Volume Parameters on Prostate Cancer Biopsies

artículo científico publicado en 2020

Comparison of two assays for human kallikrein 2

artículo científico publicado en 2003

Compliance Rates with the Prostate Cancer Research International Active Surveillance (PRIAS) Protocol and Disease Reclassification in Noncompliers.

artículo científico publicado en 2015

Compliance with biopsy recommendations of a prostate cancer risk calculator.

artículo científico publicado en 2011

Complications after prostate biopsies in men on active surveillance and its effects on receiving further biopsies in the Prostate cancer Research International: Active Surveillance (PRIAS) study.

artículo científico publicado en 2016

Complications of initial prostate biopsy in a European randomized screening trial

artículo científico publicado en 2013

Concordance of cribriform architecture in matched prostate cancer biopsy and radical prostatectomy specimens

scientific article published on 02 August 2019

Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative: A Prerequisite for Future Studies

scientific article published on 13 September 2018

Could Differences in Treatment Between Trial Arms Explain the Reduction in Prostate Cancer Mortality in the European Randomized Study of Screening for Prostate Cancer?

scientific article published on 28 March 2019

Creating a potential diagnostic for prostate cancer risk stratification (InformMDx™) by translating novel scientific discoveries concerning cAMP degrading phosphodiesterase-4D7 (PDE4D7)

scientific article published on 25 January 2019

Cribriform architecture in radical prostatectomies predicts oncological outcome in Gleason score 8 prostate cancer patients

artículo científico publicado en 2020

Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer

artículo científico publicado en 2014

Critical assessment of prebiopsy parameters for predicting prostate cancer metastasis and mortality.

artículo científico publicado en 2011

Crystals cause acute necrotic cell death in renal proximal tubule cells, but not in collecting tubule cells

artículo científico publicado en 2005

CyberKnife stereotactic radiotherapy as monotherapy for low- to intermediate-stage prostate cancer: early experience, feasibility, and tolerance

artículo científico publicado en 2010

Cystoscopy revisited as the gold standard for detecting bladder cancer recurrence: diagnostic review bias in the randomized, prospective CEFUB trial.

artículo científico publicado en 2010

De klinische relevantie van cribriforme en intraductale prostaatkanker in diagnostische naaldbiopten

Defining a standard set of patient-centered outcomes for men with localized prostate cancer

artículo científico publicado en 2014

Defining and predicting indolent and low risk prostate cancer

artículo científico

Development and Prospective Randomized Evaluation of a Decision Aid for Prostate-specific Antigen-based Early Detection of Prostate Cancer in Men Aged Between 55 and 69Yr: The PSAInForm Trial

artículo científico publicado en 2019

Development and clinical validation of a real-time PCR assay for PITX2 DNA methylation to predict prostate-specific antigen recurrence in prostate cancer patients following radical prostatectomy

artículo científico publicado en 2012

Diagnostic value of OCT3/4 for pre-invasive and invasive testicular germ cell tumours.

artículo científico publicado en 2005

Differences in Treatment and Outcome After Treatment with Curative Intent in the Screening and Control Arms of the ERSPC Rotterdam

scientific article published on 18 October 2014

Differential expression of protease activity in serum samples of prostate carcinoma patients with metastases

artículo científico publicado en 2010

Digital rectal examination is no longer necessary in the routine follow-up of men with undetectable prostate specific antigen after radical prostatectomy: the implications for follow-up

artículo científico publicado en 2005

Discrimination between Nontumor Bladder Tissue and Tumor by Raman Spectroscopy

artículo científico publicado en 2006

Disease-specific and patient-reported outcomes under active surveillance

artículo científico publicado en 2015

Disease-specific death and metastasis do not occur in patients with Gleason score ≤6 at radical prostatectomy

artículo científico publicado en 2015

Disease-specific mortality may underestimate the total effect of prostate cancer screening

artículo científico publicado en 2010

Disease-specific survival of men with prostate cancer detected during the screening interval: results of the European randomized study of screening for prostate cancer-Rotterdam after 11 years of follow-up.

artículo científico publicado en 2011

Do Treatment Differences between Arms Affect the Main Outcome of ERSPC Rotterdam?

artículo científico publicado en 2015

Do anxiety and distress increase during active surveillance for low risk prostate cancer?

artículo científico publicado en 2010

Does PSA velocity predict prostate cancer in pre-screened populations?

artículo científico publicado en 2006

Does local treatment of the prostate in advanced and/or lymph node metastatic disease improve efficacy of androgen-deprivation therapy? A systematic review

artículo científico publicado en 2010

Dutasteride Treatment Over 2 Years Delays Prostate-specific Antigen Progression in Patients with Biochemical Failure After Radical Therapy for Prostate Cancer: Results from the Randomised, Placebo-controlled Avodart After Radical Therapy for Prostate

artículo científico publicado en 2012

EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)

artículo científico publicado en 2019

Early detection of prostate cancer in 2007. Part 1: PSA and PSA kinetics.

artículo científico publicado en 2007

Effect of pathologic revision and Ki67 and ERG immunohistochemistry on predicting radical prostatectomy outcome in men initially on active surveillance.

artículo científico publicado en 2017

Eleven-year outcome of patients with prostate cancers diagnosed during screening after initial negative sextant biopsies.

artículo científico publicado en 2009

Evaluation of diffusion-weighted MR imaging at inclusion in an active surveillance protocol for low-risk prostate cancer

artículo científico publicado en 2013

Evolution of the androgen receptor pathway during progression of prostate cancer.

artículo científico publicado en 2006

Excess all-cause mortality in the evaluation of a screening trial to account for selective participation.

artículo científico publicado en 2013

Exosomes as Biomarker Treasure Chests for Prostate Cancer

artículo científico publicado el 29 de diciembre de 2010

Expert consensus document: Semantics in active surveillance for men with localized prostate cancer - results of a modified Delphi consensus procedure

artículo científico

False-negative Prostate Needle Biopsies: Frequency, Histopathologic Features, and Follow-up

artículo científico publicado en 2010

Fertility potential in a cohort of 65 men with previously acquired undescended testes

artículo científico publicado en 2013

Fibroblast growth factor receptor 3 mutation analysis on voided urine for surveillance of patients with low-grade non-muscle-invasive bladder cancer.

artículo científico publicado en 2010

Focal therapy in prostate cancer: international multidisciplinary consensus on trial design.

artículo científico

Gene therapy in The Netherlands: highlights from the Low Countries

artículo científico publicado en 2007

Gene therapy in urology: strategies to translate theory into practice

artículo científico publicado en 2005

Gene transfer vectors targeted to human prostate cancer: do we need better preclinical testing systems?

artículo científico publicado en 2010

Genetic Aspects and Molecular Testing in Prostate Cancer: A Report from a Dutch Multidisciplinary Consensus Meeting

artículo científico publicado en 2023

Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers

artículo científico publicado en 2012

Gleason score 7 screen-detected prostate cancers initially managed expectantly: outcomes in 50 men

scientific article published on 19 January 2009

Head-to-head comparison of prostate cancer risk calculators predicting biopsy outcome.

artículo científico publicado en 2018

High-dose-rate brachytherapy and external-beam radiotherapy for hormone-naïve low- and intermediate-risk prostate cancer: a 7-year experience

artículo científico publicado en 2012

Higher free testosterone level is associated with faster visual processing and more flanker interference in older men.

artículo científico publicado en 2008

Histopathological characteristics of lymph node metastases predict cancer-specific survival in node-positive prostate cancer

artículo científico publicado en 2008

Hyaluronan is apically secreted and expressed by proliferating or regenerating renal tubular cells

artículo científico publicado en 2005

Identification and characterisation of adenovirus specific T cell responses in prostate cancer patients receiving ADV5-RSV-TK gene therapy

article

Identifying and characterizing "escapes"-men who develop metastases or die from prostate cancer despite screening (ERSPC, section Rotterdam).

artículo científico publicado en 2011

Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancer

artículo científico publicado en 2011

Identifying the relationship between postoperative urinary continence and residual urethra stump measurements in robot assisted radical prostatectomy patients

artículo científico publicado en 2020

Immuno-based detection of extracellular vesicles in urine as diagnostic marker for prostate cancer

artículo científico publicado en 2015

Immunotherapy for superficial bladder cancer

artículo científico publicado en 2004

Impacts of a population-based prostate cancer screening programme on excess total mortality rates in men with prostate cancer: a randomized controlled trial

artículo científico publicado en 2013

Impacts of a population-based prostate cancer screening programme on excess total mortality rates in men with prostate cancer: a randomized controlled trial

artículo científico publicado en 2013

Improved Prostate Cancer Biopsy Grading by Incorporation of Invasive Cribriform and Intraductal Carcinoma in the 2014 Grade Groups

artículo científico publicado en 2019

Improved cancer specificity in PSA assay using Aleuria aurantia lectin coated Eu-nanoparticles for detection

artículo científico publicado en 2016

Infectious complications and hospital admissions after prostate biopsy in a European randomized trial

artículo científico publicado en 2012

Informed decision making on PSA testing for the detection of prostate cancer: an evaluation of a leaflet with risk indicator

artículo científico publicado en 2010

Infrequent Microsatellite Instability in Urothelial Cell Carcinoma of the Bladder in Young Patients

scientific article published on 04 January 2006

Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers

artículo científico publicado en 2019

Intermittent versus continuous cyproterone acetate in bone metastatic prostate cancer: results of a randomized trial

artículo científico publicado en 2013

Intraductal carcinoma has minimal impact on Grade Group assignment in prostate cancer biopsy and radical prostatectomy specimens

artículo científico publicado en 2020

Intraoperative assessment and reporting of radical prostatectomy specimens to guide nerve-sparing surgery in prostate cancer patients (NeuroSAFE)

scientific article published on 18 June 2020

Is it necessary to detect all prostate cancers in men with serum PSA levels <3.0 ng/ml? A comparison of biopsy results of PCPT and outcome-related information from ERSPC.

artículo científico publicado en 2008

Is magnetic resonance imaging-targeted biopsy a useful addition to systematic confirmatory biopsy in men on active surveillance for low-risk prostate cancer? A systematic review and meta-analysis

article

Is prostate-specific antigen velocity selective for clinically significant prostate cancer in screening? European Randomized Study of Screening for Prostate Cancer (Rotterdam).

artículo científico publicado en 2008

Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis

article

Long-term follow-up after active surveillance or curative treatment: quality-of-life outcomes of men with low-risk prostate cancer.

artículo científico publicado en 2017

Long-term follow-up of T1 high-grade bladder cancer after intravesical bacille Calmette-Guérin treatment

artículo científico publicado en 2010

MRI pathway and TRUS‐guided biopsy for detecting clinically significant prostate cancer

Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis.

artículo científico publicado en 2014

Management and survival of screen-detected prostate cancer patients who might have been suitable for active surveillance.

artículo científico publicado en 2006

Markers predicting response to bacillus Calmette-Guérin immunotherapy in high-risk bladder cancer patients: a systematic review

artículo científico publicado en 2011

Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing: New Insights from the European Randomized Study of Screening for Prostate Cancer

artículo científico publicado en 2015

Microsatellite analysis of voided-urine samples for surveillance of low-grade non-muscle-invasive urothelial carcinoma: feasibility and clinical utility in a prospective multicenter study (Cost-Effectiveness of Follow-Up of Urinary Bladder Cancer tr

artículo científico publicado en 2008

Multicenter clinical validation of PITX2 methylation as a prostate specific antigen recurrence predictor in patients with post-radical prostatectomy prostate cancer

artículo científico publicado en 2010

Nitroreductase-based therapy of prostate cancer, enhanced by raising expression of heat shock protein 70, acts through increased anti-tumour immunity

artículo científico publicado en 2005

Novel long non-coding RNAs are specific diagnostic and prognostic markers for prostate cancer

artículo científico publicado en 2015

Novel tools to improve patient selection and monitoring on active surveillance for low-risk prostate cancer: a systematic review

artículo científico

On the use of prostate-specific antigen for screening of prostate cancer in European Randomised Study for Screening of Prostate Cancer

artículo científico publicado en 2010

Optimization of nonmuscle invasive bladder cancer recurrence detection using a urine based FGFR3 mutation assay

artículo científico publicado en 2011

Orgasmic dysfunction after open radical prostatectomy: clinical correlates and prognostic factors

scientific article published on 13 November 2009

Outcomes of a bladder cancer screening program using home hematuria testing and molecular markers.

artículo científico publicado en 2013

Outcomes of initially expectantly managed patients with low or intermediate risk screen-detected localized prostate cancer

artículo científico publicado en 2012

Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly

scientific article published on 17 September 2008

Overestimation of prostate cancer mortality and other-cause mortality by the Kaplan-Meier method

artículo científico publicado en 2013

Oxalate is toxic to renal tubular cells only at supraphysiologic concentrations

artículo científico publicado en 2005

PSA level changes over time in men with an initial PSA level of < or = 4 ng/ml

artículo científico publicado en 2006

Pathological stage review is indicated in primary pT1 bladder cancer

artículo científico publicado en 2009

Positive predictive value of prostate biopsy indicated by prostate-specific-antigen-based prostate cancer screening: trends over time in a European randomized trial*.

artículo científico publicado en 2012

Pre-clinical safety assessment of Ad[I/PPT-E1A], a novel oncolytic adenovirus for prostate cancer

artículo científico publicado en 2014

Preclinical safety assessment of Ad[I/PPT-E1A], a novel oncolytic adenovirus for prostate cancer

artículo científico publicado en 2014

Prediction of prostate cancer in unscreened men: external validation of a risk calculator

artículo científico publicado en 2010

Prediction of prostate cancer risk: the role of prostate volume and digital rectal examination in the ERSPC risk calculators

artículo científico publicado en 2011

Predictive models in diagnosing indolent cancer.

artículo científico publicado en 2009

Predictive role of free prostate-specific antigen in a prospective active surveillance program (PRIAS).

artículo científico publicado en 2015

Predictive value of four kallikrein markers for pathologically insignificant compared with aggressive prostate cancer in radical prostatectomy specimens: results from the European Randomized Study of Screening for Prostate Cancer section Rotterdam.

artículo científico publicado en 2013

Predictors of unfavourable repeat biopsy results in men participating in a prospective active surveillance program

artículo científico publicado en 2011

Presence of invasive cribriform or intraductal growth at biopsy outperforms percentage grade 4 in predicting outcome of Gleason score 3+4=7 prostate cancer.

artículo científico publicado en 2017

Profiling of antibody production against xenograft-released proteins by protein microarrays discovers prostate cancer markers

artículo científico publicado en 2011

Prognostic factors for and outcome of locally advanced prostate cancer after radical prostatectomy

artículo científico publicado en 2009

Prognostic value of molecular markers, sub-stage and European Organisation for the Research and Treatment of Cancer risk scores in primary T1 bladder cancer.

artículo científico publicado en 2012

Prognostic value of serum markers for prostate cancer

artículo científico publicado en 2005

Prospective multicenter evaluation of the Beckman Coulter Prostate Health Index using WHO calibration

artículo científico publicado en 2012

Prospective validation of a risk calculator which calculates the probability of a positive prostate biopsy in a contemporary clinical cohort.

artículo científico publicado en 2012

Prospective validation of active surveillance in prostate cancer: the PRIAS study

scientific article published on 25 May 2007

Prostate Carcinoma Grade and Length But Not Cribriform Architecture at Positive Surgical Margins Are Predictive for Biochemical Recurrence After Radical Prostatectomy

artículo científico publicado en 2020

Prostate Health Index improves multivariable risk prediction of aggressive prostate cancer

artículo científico publicado en 2016

Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer

scientific article published on 25 April 2019

Prostate Magnetic Resonance Imaging, with or Without Magnetic Resonance Imaging-targeted Biopsy, and Systematic Biopsy for Detecting Prostate Cancer: A Cochrane Systematic Review and Meta-analysis

scientific article published on 18 July 2019

Prostate cancer gene therapy: Preliminary clinical and pre-clinical results

article

Prostate cancer in the Swedish section of ERSPC--evidence for less metastases at diagnosis but not for mortality reduction

artículo científico publicado en 2006

Prostate cancer mortality in screen and clinically detected prostate cancer: estimating the screening benefit.

artículo científico publicado en 2009

Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)

artículo científico publicado en 2009

Prostate cancer outcomes of men with biopsy Gleason score 6 and 7 without cribriform or intraductal carcinoma

artículo científico publicado en 2016

Prostate cancer screening in Europe and Asia.

artículo científico publicado en 2016

Prostate cancer upgrading with serial prostate MRI scans and repeat biopsy in men on active surveillance: are confirmatory biopsies still necessary?

scientific article published on 31 March 2020

Prostate health index (PHI) and prostate-specific antigen (PSA) predictive models for prostate cancer in the Chinese population and the role of digital rectal examination-estimated prostate volume.

artículo científico publicado en 2016

Prostate-cancer mortality at 11 years of follow-up

artículo científico publicado en 2012

Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection.

artículo científico publicado en 2010

Prostate-specific antigen kinetics in clinical decision-making during active surveillance for early prostate cancer--a review.

artículo científico publicado en 2008

Prostate-specific antigen screening can be beneficial to younger and at-risk men.

artículo científico publicado en 2012

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition

artículo científico publicado en 2018

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition.

artículo científico publicado en 2018

Prostate-specific antigen-based prostate cancer screening: reduction of prostate cancer mortality after correction for nonattendance and contamination in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer

artículo científico publicado en 2013

Psychological aspects of active surveillance

artículo científico publicado en 2012

Quality-of-life effects of prostate-specific antigen screening.

artículo científico publicado en 2012

Radical Prostatectomy for Low-Risk Prostate Cancer Following Initial Active Surveillance: Results From a Prospective Observational Study

scientific article published on 14 February 2012

Radical prostatectomy versus deferred treatment for localised prostate cancer

artículo científico publicado en 2020

Re: Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured as age 44 to 50 years

artículo científico publicado en 2007

Real-time Watchful Surveillance Looks Like Active Waiting.

artículo científico publicado en 2017

Reasons for Discontinuing Active Surveillance: Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium

article by Mieke Van Hemelrijck et al published 29 October 2018 in European Urology

Reasons for Discontinuing Active Surveillance: Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium

article by Mieke Van Hemelrijck et al published March 2019 in European Urology

Reducing unnecessary biopsies while detecting clinically significant prostate cancer including cribriform growth with the ERSPC Rotterdam risk calculator and 4Kscore

scientific article published on 07 December 2018

Reduction of MRI-targeted biopsies in men with low-risk prostate cancer on active surveillance by stratifying to PI-RADS and PSA-density, with different thresholds for significant disease.

artículo científico publicado en 2018

Relationship Between Baseline Prostate-specific Antigen on Cancer Detection and Prostate Cancer Death: Long-term Follow-up from the European Randomized Study of Screening for Prostate Cancer

Reply from authors re: Brant A. Inman, Michael R. Abern. Interpreting a study on bladder cancer screening. Eur Urol 2013;64:48-50: the goal of cancer screening: early evaluation of screening for bladder cancer.

artículo científico publicado en 2013

Reply from authors re: Michael Baum. Screening for prostate cancer: can we learn from the mistakes of the breast screening experience? Eur Urol 2013;64:540-1: screening for prostate cancer: we have learned and are still learning.

artículo científico publicado en 2013

Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations-A Report of a European School of Oncology Task Force

artículo científico publicado en 2016

Restricting False-positive Magnetic Resonance Imaging Scans to Reduce Overdiagnosis of Prostate Cancer

artículo científico publicado en 2020

Risk-based Patient Selection for Magnetic Resonance Imaging-targeted Prostate Biopsy after Negative Transrectal Ultrasound-guided Random Biopsy Avoids Unnecessary Magnetic Resonance Imaging Scans.

artículo científico publicado en 2015

Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer

artículo científico publicado en 2017

Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.

artículo científico publicado en 2017

Rotterdam Randomized Pilot Studies of Screening for Prostate Cancer—An Overview After 10 Years

artículo científico publicado en 2005

Rule-based versus probabilistic selection for active surveillance using three definitions of insignificant prostate cancer

artículo científico publicado en 2015

Salvage radiotherapy after radical prostatectomy: Long-term results of urinary incontinence, toxicity and treatment outcomes.

artículo científico publicado en 2018

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

artículo científico publicado en 2014

Screening and prostate-cancer mortality in a randomized European study

artículo científico publicado en 2009

Screening for prostate cancer in 2008 II: the importance of molecular subforms of prostate-specific antigen and tissue kallikreins.

artículo científico publicado en 2008

Screening for prostate cancer: results of the Rotterdam section of the European randomized study of screening for prostate cancer.

artículo científico publicado en 2013

Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study

scientific article published on 23 November 2011

Serum levels of arachidonic acid metabolites change during prostate cancer progression

artículo científico publicado en 2014

Setting an Agenda for Assessment of Health-related Quality of Life Among Men with Prostate Cancer on Active Surveillance: A Consensus Paper from a European School of Oncology Task Force

artículo científico publicado en 2016

Sewage surveillance system using urological wastewater: Key to COVID-19 monitoring?

scientific article published on 13 October 2020

Sexual function with localized prostate cancer: active surveillance vs radical therapy.

artículo científico publicado en 2012

Short-term outcomes of the prospective multicentre 'Prostate Cancer Research International: Active Surveillance' study.

artículo científico publicado en 2009

Should prostate-specific antigen screening be offered to asymptomatic men?

artículo científico publicado en 2010

Should we involve patients more actively? Perspectives of the multidisciplinary team on shared decision-making for older patients with metastatic castration-resistant prostate cancer

scientific article published on 11 January 2019

Sonography, CT, and MRI of giant cavernous hemangioma of the kidney: correlation with pathologic findings

artículo científico publicado en 2004

Stereotactic body radiotherapy with a focal boost to the MRI-visible tumor as monotherapy for low- and intermediate-risk prostate cancer: early results

artículo científico publicado en 2013

Summary statement on screening for prostate cancer in Europe

artículo científico publicado en 2017

T cell activation upon exposure to patient-derived tumor tissue: a functional assay to select patients for adoptive T cell therapy

artículo científico publicado en 2010

Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study

artículo científico publicado en 2014

The Association of the Long Prostate Cancer Expressed PDE4D Transcripts to Poor Patient Outcome Depends on the Tumour's TMPRSS2-ERG Fusion Status

scientific article published on 02 June 2019

The European Prostate Cancer Centres of Excellence: A Novel Proposal from the European Association of Urology Prostate Cancer Centre Consensus Meeting

scientific article published on 22 February 2019

The FGFR3 mutation is related to favorable pT1 bladder cancer.

artículo científico publicado en 2011

The Movember Foundation's GAP3 cohort: A profile of the largest global prostate cancer active surveillance database to date

artículo científico publicado en 2017

The Prognostic PDE4D7 Score in a Diagnostic Biopsy Prostate Cancer Patient Cohort with Longitudinal Biological Outcomes.

artículo científico publicado en 2018

The Prostate cancer Research International: Active Surveillance study

artículo científico publicado en 2012

The additional value of TGFβ1 and IL-7 to predict the course of prostate cancer progression

artículo científico publicado en 2011

The development of multiple bladder tumour recurrences in relation to the FGFR3 mutation status of the primary tumour.

artículo científico publicado en 2009

The effect of study arm on prostate cancer treatment in the large screening trial ERSPC.

artículo científico publicado en 2010

The future of prostate cancer research: bringing data together, looking back and forward.

artículo científico publicado en 2018

The human PC346 xenograft and cell line panel: a model system for prostate cancer progression

artículo científico publicado en 2006

The long-term relationship between a real change in prostate volume and a significant change in lower urinary tract symptom severity in population-based men: the Krimpen study.

artículo científico publicado en 2007

The mutational landscape of prostate cancer

artículo científico publicado en 2013

The prostate health index selectively identifies clinically significant prostate cancer

artículo científico publicado en 2014

The requirements of a specialist Prostate Cancer Unit: a discussion paper from the European School of Oncology.

artículo científico publicado en 2010

The role of adjuvant hormonal treatment after surgery for localized high-risk prostate cancer: results of a matched multiinstitutional analysis

artículo científico publicado en 2012

The value of EZH2, p27(kip1), BMI-1 and MIB-1 on biopsy specimens with low-risk prostate cancer in selecting men with significant prostate cancer at prostatectomy.

artículo científico publicado en 2009

Timing of curative treatment for prostate cancer: a systematic review

artículo científico publicado en 2013

Tissue proteomics outlines AGR2 AND LOX5 as markers for biochemical recurrence of prostate cancer

scientific article published on 23 November 2018

Towards an optimal interval for prostate cancer screening.

artículo científico publicado en 2011

Toxicity and quality of life after high-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancer

artículo científico publicado en 2015

Truncated ETV1, fused to novel tissue-specific genes, and full-length ETV1 in prostate cancer.

artículo científico publicado en 2008

Tumor protection by IL-7 secreting whole cell vaccine is merely mediated by NK1.1-positive cells

artículo científico publicado en 2012

Validation of Cyclic Adenosine Monophosphate Phosphodiesterase-4D7 for its Independent Contribution to Risk Stratification in a Prostate Cancer Patient Cohort with Longitudinal Biological Outcomes.

artículo científico publicado en 2017

Validation of the Urogenital Distress Inventory (UDI-6) and Incontinence Impact Questionnaire (IIQ-7) in a Dutch population.

artículo científico publicado en 2013

Words of wisdom. Re: Prostate cancer stem cells: a new target for therapy. Maitland NJ, Collins AT

artículo científico publicado en 2008

Words of wisdom. Re: effects of pathologic stage on the learning curve for radical prostatectomy: evidence that recurrence in organ-confined cancer is largely related to inadequate surgical technique.

artículo científico publicado en 2008

[-2]pro-prostate specific antigen as an aid in prostate biopsy

artículo científico publicado en 2012

[Analysis of the microsatellite instability gene mutation in the urothelial tumor of the upper urinary tract]

artículo científico publicado en 2005

[Early detection of prostate cancer--recommendations after 13 years of follow-up in the European randomised study]

artículo científico publicado en 2015

[MRI/US-fusion for targeted prostate biopsy]

artículo científico publicado en 2014

[Presence of prostate cancer, but absence of active treatment]

artículo científico publicado en 2019

hK2 and free PSA, a prognostic combination in predicting minimal prostate cancer in screen-detected men within the PSA range 4-10 ng/ml.

artículo científico publicado en 2007